SGMO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Sangamo Therapeutics Inc (SGMO) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is severely declining, technical indicators are bearish, and there are no positive catalysts or strong trading signals to support a buy decision.
The technical indicators for SGMO are bearish. The MACD is negative and expanding downward, the RSI is neutral at 41.11, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 0.356, with resistance levels at 0.454 and 0.551. Overall, the technical setup does not suggest a favorable entry point.
NULL identified. There are no recent news updates, no significant hedge fund or insider trading activity, and no recent congress trading data. The stock has no strong trading signals from AI Stock Picker or SwingMax.
The company's financials have significantly deteriorated, with a YoY revenue drop of -98.82%, net income down -472.19%, and EPS down -375.00%. Technical indicators are bearish, and there is no evidence of positive sentiment or momentum in the options or trading data.
In Q3 2025, Sangamo Therapeutics reported a revenue drop to $581,000 (-98.82% YoY), net income of -$34.93 million (-472.19% YoY), and EPS of -0.11 (-375.00% YoY). The gross margin remained at 100%, but the overall financial performance indicates severe challenges.
No recent analyst rating or price target changes are available for SGMO.
